Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The application of high-dose interleukin-2 for metastatic renal cell carcinoma.

The application of high-dose interleukin-2 for metastatic renal cell carcinoma. Med Oncol. 2009; 26 Suppl 1:13-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.